6.

The Agency shall establish within its web portal a publicly accessible webpage that provides information on actual shortages of medicinal products included in the critical medicines lists in cases in which the Agency has assessed the shortage and has provided recommendations to healthcare professionals and patients. The webpage shall provide at least the following information: the name and common name of the medicinal product on the critical medicines lists; the therapeutic indications for the medicinal product on the critical medicines lists; the reason for the shortage of the medicinal product on the critical medicines lists; the start and end dates of the shortage of the medicinal product on the critical medicines lists; the Member States affected by the shortage of the medicinal product on the critical medicines lists; other relevant information for healthcare professionals and patients, including information on whether alternative medicinal products are available. The webpage referred to in the first subparagraph shall also provide references to national registries on shortages of medicinal products.

← art_6__para_5__text_1 · All articles · art_6__para_6__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.